Aardvark Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Assets | ||
| Cash & Equivalents | $47.1M | $61.6M |
| Accounts Receivable | — | — |
| Inventory | — | — |
| Total Current Assets | $111.9M | $74.1M |
| Property, Plant & Equipment | — | — |
| Goodwill | — | — |
| Intangible Assets (Excl. Goodwill) | — | — |
| Total Assets | $117.2M | $77.5M |
| Liabilities | ||
| Accounts Payable | $2.1M | $2.3M |
| Total Current Liabilities | $10.5M | $4.9M |
| Long-Term Debt | — | — |
| Total Liabilities | $10.5M | $5.4M |
| Stockholders' Equity | ||
| Retained Earnings | $-115.9M | $-58.3M |
| Total Stockholders' Equity | $106.6M | $-54.6M |